As of 2025-08-03, the Fair Value of aTyr Pharma Inc (ATYR) is -2.87 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.70 USD, the upside of aTyr Pharma Inc is -161.10%.
With the market price of 4.70 USD and our fair value calculation, aTyr Pharma Inc (ATYR) is not a good investment. Investing in ATYR stocks now will result in a potential loss of 161.10%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -16.22 | -33.77 | -45.34 | -50.39 | -64.02 | -41.95 |
| YoY growth | 31.26% | -108.14% | -34.26% | -11.14% | -27.06% | -29.87% |
| Market Cap (mil) | 518.90 |
| P/E | |
| Forward P/E |
| EPS | -0.57 |
| Avg earnings growth rate | -29.87% |
| TTM earnings | -63.41 |